2009,my country's pharmaceutical foreign trade is well run well，Import and export of pharmaceuticals and health products increases against the trend，The total import and export value reaches 53.1 billion US dollars，Create a new high in history。 
    Basically stable operation throughout the year
    2009，my country's pharmaceutical foreign trade is moving forward，The import and export value of pharmaceuticals and health products reached 53.15 billion US dollars，increased by 9.8%year -on -year。Where，Imported 20.236 billion US dollars，year -on -year increased by 21.5%; exports 32.91 billion U.S. dollars，increased by 3.7%year -on -year。Pharmaceutical foreign trade surplus 12.67 billion US dollars，reduced 16.6%year -on -year。
    Exit，The total export of Chinese medicine products is 1.462 billion US dollars，increased by 11.72%year -on -year，The proportion of the total export of all medical insurance products in my country is 4.44%; the export of western medicine products is 19.2 billion US dollars，decreased by 0.8%year -on -year，The proportion of the total export of all medical insurance products is 58.4%; the export of medical device products is US $ 12.25 billion，increased by 10.64%year -on -year，The proportion of the total export of all medical insurance products is 37%。
    Import aspect，Chinese medicine products imported 542 million US dollars，year -on -year increase of 22.14%，accounting for 2.68%of the total import amount; US $ 13.59 billion in western medicine products，increased by 23.6%year -on -year，The proportion of the total export of all medical insurance products is 67.3%; the import of medical device products is 6.1 billion US dollars，increased by 17%year -on -year，The proportion of the total export of all medical insurance products is 30.2%。
    From the perspective of classified products，Biochemical drugs、Medical auxiliary materials and plant extracts Entry and export trade performance active，Obvious growth。Where，Biochemical drug exports 1.446 billion US dollars，increased by 60.22%year -on -year，The first increase in exports of high residence; imports 1.019 billion U.S. dollars，increased by 31.8%year -on -year。Oral equipment and materials exports 248 million US dollars，increased by 23.62%year -on -year，Imported US $ 126 million，increased by 27.39%year -on -year。Plant extract exports 655 million US dollars，increased by 23.69%year -on -year; imports of US $ 162 million，rose 129.19%year -on -year，The top of the Rap the Import Rap the list。In addition，Medical dressing and Western Academy performed well，The former exported a total of $ 4.136 billion，increased by 32.85%year -on -year，ranked first in the export amount of medical device categories; the import of western medicines increased by 22.2%year -on -year，up to $ 4.858 billion，ranked second in the import amount，second only to Western medicine raw materials。In addition，Hospital diagnosis and therapeutic equipment and one -time consumables such as traditional large pharmaceutical products run relatively smoothly。2009，Diagnosis and treatment equipment exports 3.77 billion US dollars，increased by 4.28%year -on -year; imports were US $ 50.14 billion，increased by 17.3%year -on -year。Disposable consumables exported 1.92 billion US dollars，increased by 3.57%year -on -year; imports 720 million US dollars，increased by 19.98%year -on -year。
    Affected by the financial crisis，Some pharmaceutical products have a decline in exports。Western medicine raw materials are the first brunt，Exit 16.56 billion US dollars，Falling 4.53 percentage points year -on -year，Leading stake betting appin a stake online sports bettingdecline。The import and export of Chinese patent medicines all atrophied，Exit and imports decreased by 4.23%and 3.88%year -on -year;，decreased by 4.96 percentage points year -on -year。
    Four characteristics of pharmaceutical foreign trade
    2009，The overall indicator of the import and export of pharmaceutical products in my country is basically the same as in 2008，Compared to the sharp decline in foreign trade in the country, it is difficult to be easy to come。All year's medical foreign trade mainly presents the following features:
    1. The continuous volume of imports rises
    2009，my country's pharmaceutical and health care products imports strong rebound，Become the main force that supports 2009 pharmaceutical foreign trade growth，Generally presenting the situation of "quantitative increase in price"。2009，The import amount of medical and health products increased by 3.52 billion US dollars over the same period last year，But when the number of imports increased by 34.8%year -on -year，The import price fell 9.89%。Among them, the most changed is the biochemical drug，The number of imports increased by 751.9%year -on -year，The price fell 84.52%。In terms of imported subjects，Western medicine raw materials、High -tech value -added products such as Xica and Hospital diagnosis and treatment equipment still occupy the dominant position，Three items account for 87%of the total imports。This volume growth is related to the decline in the exchange rate of the US dollar that causes the reduction of product import costs;、"Medical Insurance Catalog" promulgated favorable policy impact，The capacity is further expanded to drive the demand to increase rapidly。
    2. Exit stop falling back
    Standard by world economic growth，In particular, the demand for foreign markets and the influence of the trade protection policies from various countries，In the first 10 months of 2009, the export of medical products in my country fell slightly year -on -year，but starting from November，Exit occurrence occurred and stopped rising，Realize positive growth for the first time year -on -year，The increase is 0.94%，Exports in December increased by 3.7%，Exports to a single month of 3.576 billion US dollars，year -on -year and month -on -month increased by 33.8%and 19.2%, respectively，The rise of the rebound is obviously accelerated。The export volume of western medicine raw materials with a total export of more than 50%increased by 6.9%，But the average price dropped by 10.7%。Single monthly exports have continued to decline in the fourth quarter of 2008，By February 2009 to the lowest point in nearly two years。Since then rebounded quickly and tended to be stable，It has basically recovered and exceeded the same period of 2008。year -on -year，After the continuous downturn in 7 months before 2009，continuously positive growth trend for the next few months，On the one hand, it shows that the overall export stabilization is rising; on the other hand, it is also related to the low base of the export amount in the same period in 2008;，From August to December 2009, a continuous increase in increased growth、Fall、Renewal，Added uncertainty to the development of the market outlook。
    3. The export location structure is relatively stable
    2009，my country's pharmaceutical foreign trade industry has not changed significantly，The advantages of traditional provinces are still obvious。The top five provinces and cities in import and export are Shanghai、Jiangsu、Guangdong、Zhejiang、Beijing，Five provinces and cities have a total of 36.895 billion US dollars，accounting for 69.4%of the total foreign trade amount。Where，The import and export of Zhejiang Province fell 1.06%year -on -year，Other provinces and cities are growing up，The highest increase is Guangdong Province，up to 13.6%。Jiangsu、Zhejiang、Guangdong、Shanghai、Shandong Lenic Export Ranking Five Plus，Total exports 22.436 billion US dollars，accounting for 68.2%of the total export amount。Zhejiang still ranks first in the list，Exit 6.48%year -on -year，is $ 5.18 billion; the highest export of Guangdong Province has increased the highest year -on -year increase，increased 13.26 percentage points from the same period of 2008，up to US $ 4.114 billion。
    2009，The number of medical foreign trade enterprises in my country has increased My stake betting appslightly，My stake betting appAmong them, 28389 export companies，1364 more than the same period in 2008; 15486 imported companies，increased 51 from the same period in 2008。Aspect of the composition of export enterprises，The number of private enterprises accounts for about 70%，Export volume accounts for 40%of the total; "three capital" enterprises account for about 20%，Among them, two -thirds are wholly foreign -owned enterprises; the proportion of state -owned enterprises is less than 10%，But contributed nearly 20%of the export value。Materials and drug production enterprises and large state -owned pharmaceutical foreign trade enterprises are still the main force of exports of pharmaceutical products。
    4. The traditional target market remains unchanged
    2009，The share of my country's pharmaceutical products in the international market remains unchanged，Asia、Europe and North America's three -legged situation continues to maintain，A total of 91.4%of the share。Where，Asia Continue to live first，Leading with 19.47 billion US dollars，Europe subsequently with 18.886 billion US dollars，North America ranks third with US $ 10.22 billion。Compared with the same period of 2008，my country to Asia、Entry and exports in Europe and North America increased by 11.54%year -on -year、11.4%and 4.76%，Reflect that the potential of trade with these areas is huge。It is worth noting that it is，Since March 2009，my country's trade with European pharmaceuticals and health care products from a surplus reversal deficit，The annual deficit amount is US $ 864 million。
    Look at the country or region of the exported destination，United States、Japan、India、Germany and South Korea are the top five exports in my country，accounting for 46.6%of my country's foreign exports。Where，my country exports to the United States 6.238 billion US dollars，decreased by 0.06%year -on -year。In the top 20 countries or regions,，my country to the Netherlands、Brazil、Indonesia and other countries have a relatively obvious decrease compared to the same period in 2008，A decline exceeds 6%,exports to France and Vietnam showed rising against the trend with 40.94%and 63.2%, respectively.。
    From the perspective of imported countries or regions，Most of the imports of Chinese pharmaceutical products come from developed countries，The top 5 are in the United States、Germany、Japan、Swiss、France，Five Kingdoms accounts for 52.6%of the total imports of Chinese pharmaceutical imports。Where，The United States takes the first place to import a single country for a single country with a import value of US $ 3.56 billion，increased by 15.3%year -on -year; imports from Switzerland increased by 34%year -on -year，up to $ 10.44 billion，Show good growth potential。Due to the rapid growth of imports，my country to Germany、French and Belgian pharmaceutical foreign trade has experienced a higher deficit，Among them, the deficit against Germany is 557 million US dollars，higher than the EU overall deficit，an increase of 632.9%year -on -year; the deficit of France was 229 million US dollars，decreased by 37.4%year -on -year; the Belgian deficit is 146 million US dollars，increased by 586.7%year -on -year。
    multinational pharmaceutical companies to speed up the pace of expansion in China
    2009，The shadow of the international financial crisis continues to cover it，The pharmaceutical market of developed countries such as Europe and the United States is growing slowly。Under the promotion of a new round of pharmaceutical industry in the world，The investment actions of multinational pharmaceutical companies in emerging markets are becoming more frequent，Its depth and breadth are also expanding。my country has a huge market、Rich and cheap labor，and low -cost clinical trial resources，The pharmaceutical market has increased for many years at an average annual speed of 20%or more，Plus the implementation of the new medical reform plan，Make multinational pharmaceutical companies significantly accelerate the pace of expansion of China。
    2009，​​my country's pharmaceutical industry uses foreign capital methods to have both wholly -owned and joint ventures and cooperation。Current，The number of joint ventures and wholly -owned enterprises accounts for about 30%of the total number of pharmaceutical companies in my country，Sales account for about stake betting app26%to Stake Sports Betting27%of the sales of the entire pharmaceutical product，is one of the important characters in the Chinese pharmaceutical market。Pfizer、Merhado、Roche、GSK、Nova、Bayer and other top 20 major pharmaceutical companies in the world have invested in factories in China，Many foreign companies have also established a large -scale R & D center，and extend the tentacles in the field of drug wholesale，The market share in large and medium -sized cities continues to increase。According to statistics from the Ministry of Commerce，In 2009, 223 new foreign -invested enterprises in the pharmaceutical industry in my country，decreased by 15.21%year -on -year; the actual amount of foreign capital was 1.111 billion US dollars，increased by 33.66%year -on -year。
   Trade friction increases significantly
    Since the financial crisis，Many countries are impacted by the financial crisis，For the consideration of protecting the interests of the country，Made in Chinese products，Especially low -end pharmaceutical products are limited，A significant increase in trade relief measures to China。
    2009，Trade frictions in my country's pharmaceutical and health care industry are mainly concentrated on anti -dumping surveys of Chinese products abroad，There are 4 cases of initiating the case，The product involved in the case includes a disposable syringe、penicillin industrial salt、Sodium glucose，The amount involved in the case is $ 140 million，The country involved in Argentina、India and EU。Its characteristics are: First, the scope of the product involved is expanded from the raw materials to medical device products。In the past，More than 90%of the products that have been surveyed by foreign anti -dumping surveys in my country，and since the second half of 2008，my country's disposable syringe is by Brazil、Ukraine mentioned since anti -dumping survey，In September 2009, Argentina launched an anti -dumping survey on the same product，The amount involved is $ 4.58 million。Second, the country involved in the case expands from traditional markets to emerging markets。In the past，Medical products mainly suck the country to be India，Starting from 2008，Some emerging markets like Brazil、Ukraine and Argentina have also begun to launch an anti -dumping survey on Chinese products。Third, the amount involved increased year by year。Before 2006，The amount involved in the case is less than 10 million US dollars，In 2006, India launched an anti -dumping survey on penicillin industrial salt，The amount involved is $ 99.5 million，In 2007, India raised an anti -dumping survey against cephalosporin，The amount involved in the case was $ 15.6 million; in 2009, India raised anti -dumping surveys to my country's production of penicillin industrial salt，The amount involved reached 130 million US dollars,Become the largest case involved in the international anti -dumping of Chinese pharmaceutical products。Fourth, the same product has repeatedly raised anti -dumping surveys in different countries or the same country，If a disposable syringe, there are 3 different countries in different countries in one year.，and India has also launched a survey for my country's penicillin industrial salt 3 times。
    Opportunities and challenges coexist
    Current，The international financial crisis has not yet showed signs of bottoming out，major multinational pharmaceutical companies in order to reduce costs and improve production efficiency，In general tightening expenditure、Reorganized internal agency、Adjust the focus of research and development、At the same time as the new project is launched，Added investment in emerging markets such as China，Strive to occupy more market share，to slow down the adverse effects of crisis。According to IMS statistics，2010 global pharmaceutical market increased by 4%~ 6%，The market size will exceed 825 billion US dollars，The annual compound growth rate of the global pharmaceutical market from 2013 will maintain a growth rate of 4%to 7%，At that time, the market size is expected to exceed 975 billion US dollars。and the Chinese pharmaceutical market will increase at a rate of more than 20%per year in the next 4 years，The contribution rate for the growth of the global pharmaceutical market in 2013 will reach 21%。In this background，It is expected that my country's pharmaceutical foreign My stake betting apptrade stake sports betting appdevelopment will have the following five major trends:
    (1) The growth trend of pharmaceutical foreign trade is expected to be maintained。my country's advantage in traditional community chemicals and drugs will continue，especially antibiotics、Vitamin、Anti -heat -relieving analgesics、amino acids and other products are expected to recover to increase; high -tech product exports such as West Academy and medical diagnosis and treatment equipment will also maintain a certain increase，Especially Chinese enterprises while maintaining the comparative advantage of existing small and medium -sized medical devices，With more quality and low -cost medical equipment products and technology, it has increased its pioneering efforts to high -end markets，Det independent brand、Building a marketing network will be the efforts of more and more enterprises。
    (2) Import or continue to expand pharmaceutical products。The deepening of the new medical reform and the continuous improvement of the medical insurance system，It will continue to drive the expansion of domestic demand，A large number of key medical equipment and technology, as well as western medicine、The import volume of biochemical drugs will continue to rise，Domestic enterprises will use this momentum to expand the import of pharmaceutical products。
    (3) The export of some products will continue to be blocked。Affected by factors such as overall shrinkage and stricter regulatory policies of international market demand，In 2010, the import and export of patent medicines in my country will continue to have a deficit。Some related health products and massage appliances for rehabilitation and physical therapy products are difficult to eliminate in a short time，The situation is not optimistic。
    (4) Trade friction will further increase。European and American countries continue to put pressure on my country on the appreciation of the yuan，Do not rule out a new round of currency battle，and lead to a trade war on Chinese manufacturing products。In addition，Many emerging economies are impacted by the financial crisis，For the consideration of protecting the interests of the country，It will also restrict my country's manufacturing products，So the number of trade frictions in countries in my country and emerging markets is likely to rise significantly。
    (5) More and more companies "go global"。With the enhancement of the comprehensive strength of my country's pharmaceutical companies，There will be more and more companies to seize the new round of business opportunities brought by the international financial crisis，Obbiable、Listing and external direct investment to accelerate entering the international market, especially high -end markets。Although the internationalization of my country's pharmaceutical companies is full of challenges and difficulties，But the future prospects will become more and more bright，Maximizing benefits in the international market will become the main theme of the internationalization of pharmaceutical companies in my country。